mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.52 |
0.07 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.07 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.08 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |